Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UTD1 in advanced breast cancer
CTR20150581Phase 2Completed
- Sponsor
- Biostar Pharmaceuticals
- Start
- Sep 2015
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of utidelone in breast cancer, sponsored by Biostar Pharmaceuticals. Started Sep 2015; status: completed.
02
Drugs
utidelone
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20150581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150581.